Answer
Yes. By stimulating T cells, it may oppose transplant immunosuppression and increase the risk of graft rejection. Oncology and transplant teams should assess this before treatment.
Sources for this answer
- YERVOY 5 mg/ml concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.